IL66113A - Pharmaceutical soft-gelatin capsule formulations containing ergopeptide alkaloids - Google Patents

Pharmaceutical soft-gelatin capsule formulations containing ergopeptide alkaloids

Info

Publication number
IL66113A
IL66113A IL66113A IL6611382A IL66113A IL 66113 A IL66113 A IL 66113A IL 66113 A IL66113 A IL 66113A IL 6611382 A IL6611382 A IL 6611382A IL 66113 A IL66113 A IL 66113A
Authority
IL
Israel
Prior art keywords
formulations containing
gelatin capsule
capsule formulations
pharmaceutical soft
ergopeptide
Prior art date
Application number
IL66113A
Other languages
English (en)
Other versions
IL66113A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL66113A0 publication Critical patent/IL66113A0/xx
Publication of IL66113A publication Critical patent/IL66113A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C21—METALLURGY OF IRON
    • C21C—PROCESSING OF PIG-IRON, e.g. REFINING, MANUFACTURE OF WROUGHT-IRON OR STEEL; TREATMENT IN MOLTEN STATE OF FERROUS ALLOYS
    • C21C7/00—Treating molten ferrous alloys, e.g. steel, not covered by groups C21C1/00 - C21C5/00
    • C21C7/0006—Adding metallic additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22B—PRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
    • C22B1/00—Preliminary treatment of ores or scrap
    • C22B1/14—Agglomerating; Briquetting; Binding; Granulating
    • C22B1/24—Binding; Briquetting ; Granulating
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22B—PRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
    • C22B1/00—Preliminary treatment of ores or scrap
    • C22B1/14—Agglomerating; Briquetting; Binding; Granulating
    • C22B1/24—Binding; Briquetting ; Granulating
    • C22B1/248—Binding; Briquetting ; Granulating of metal scrap or alloys

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Environmental & Geological Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Geology (AREA)
  • Manufacturing & Machinery (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL66113A 1981-06-24 1982-06-23 Pharmaceutical soft-gelatin capsule formulations containing ergopeptide alkaloids IL66113A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/277,980 US4366145A (en) 1981-06-24 1981-06-24 Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation

Publications (2)

Publication Number Publication Date
IL66113A0 IL66113A0 (en) 1982-09-30
IL66113A true IL66113A (en) 1987-02-27

Family

ID=23063180

Family Applications (1)

Application Number Title Priority Date Filing Date
IL66113A IL66113A (en) 1981-06-24 1982-06-23 Pharmaceutical soft-gelatin capsule formulations containing ergopeptide alkaloids

Country Status (29)

Country Link
US (1) US4366145A (sv)
JP (1) JPS584716A (sv)
AT (2) AT377533B (sv)
AU (1) AU561334B2 (sv)
BE (1) BE893542A (sv)
CA (1) CA1191788A (sv)
CH (1) CH655848A5 (sv)
CY (1) CY1430A (sv)
DE (1) DE3222250A1 (sv)
DK (1) DK280282A (sv)
ES (1) ES513359A0 (sv)
FI (1) FI80591C (sv)
FR (1) FR2508313B1 (sv)
GB (1) GB2100697B (sv)
GR (1) GR75952B (sv)
HK (1) HK53188A (sv)
HU (1) HU190393B (sv)
IE (1) IE53544B1 (sv)
IL (1) IL66113A (sv)
IT (1) IT1189289B (sv)
KE (1) KE3814A (sv)
MY (1) MY8600312A (sv)
NL (1) NL8202500A (sv)
NZ (1) NZ201046A (sv)
PH (1) PH22060A (sv)
PT (1) PT75100B (sv)
SE (1) SE455161B (sv)
SG (1) SG21388G (sv)
ZA (1) ZA824513B (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3307353C2 (de) * 1983-03-02 1985-01-31 R.P. Scherer GmbH, 6930 Eberbach Polyethylenglykolhaltige Weichgelatinekapsel und Verfahren zu ihrer Herstellung
GB8305693D0 (en) * 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
DE3413955A1 (de) * 1983-04-22 1984-10-25 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutisches praeparat enthaltend co-dergocrine und einen calcium-antagonisten
US4832952A (en) * 1983-07-07 1989-05-23 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
ZA845180B (en) * 1983-07-07 1986-02-26 American Home Prod Pharmaceutical composition containing a liquid lubricant
US4777048A (en) * 1983-07-07 1988-10-11 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4620974A (en) * 1983-07-07 1986-11-04 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4929640A (en) * 1988-04-04 1990-05-29 George D. McAdory Medicaments intended for combined use in the improvement of lymphocyte function
US5001117A (en) * 1989-03-07 1991-03-19 Pharmacaps, Inc. Use of lecithin to restore olfaction and taste
JPH02287913A (ja) * 1989-04-27 1990-11-28 Nec Corp トラッキング検査装置
FR2661832A1 (fr) * 1990-05-11 1991-11-15 Corbiere Jerome Procede de stabilisation d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US7771746B2 (en) * 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
CN1257711C (zh) * 2003-12-05 2006-05-31 石药集团中奇制药技术（石家庄）有限公司 丁苯酞软胶囊及其制备工艺
US20050152969A1 (en) * 2004-01-08 2005-07-14 Chiprich Timothy B. Colored liquid-filled soft capsules and method of manufacture thereof
US8741918B2 (en) 2007-06-21 2014-06-03 Veroscience Llc Parenteral formulations of dopamine agonists

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE255481C (sv) *
AT164487B (de) * 1938-02-10 1949-11-10 Climax Molybdenum Co Verfahren zur Herstellung von molybdänhaltigen Eisenlegierungen und hiezu geeignetes Legierungsmittel
US2269145A (en) * 1939-06-16 1942-01-06 Upjohn Co Stabilized ergot alkaloid preparation
US2576763A (en) * 1950-03-22 1951-11-27 Climax Molybdenum Co Vanadium containing briquettes
US2870062A (en) * 1956-04-27 1959-01-20 Scherer Corp R P Gelatin composition for capsules
DE1802666B1 (de) * 1968-10-11 1970-08-27 Elektrometallurgie Gmbh Chromhaltiges Legierungsmittel fuer Metallschmelzen
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
DE2156795C3 (de) * 1970-11-20 1980-09-25 Ugine Kuhlmann Verfahren zur Herstellung von porösen Molybdänbriketts
SU432703A3 (sv) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
FR2184460B1 (sv) * 1972-05-17 1975-06-20 Fabre Sa Pierre
US3849562A (en) * 1973-03-15 1974-11-19 Sandoz Ltd Method of treating nephrosis
GB1472255A (en) * 1973-06-15 1977-05-04 Murex Ltd Additive for steel baths
US4198391A (en) * 1973-07-20 1980-04-15 R. P. Scherer Ltd. Pharmaceutical compositions
IL46682A (en) * 1974-02-22 1979-07-25 Wellcome Found Pharmaceutical capsules containing difoxin
AT366576B (de) * 1974-02-22 1982-04-26 Wellcome Found Verfahren zur herstellung von pharmazeutischen praeparaten
US4078065A (en) * 1974-07-04 1978-03-07 Sandoz Ltd. Organic compounds
DE2528257C2 (de) * 1974-07-04 1986-02-13 Sandoz-Patent-GmbH, 7850 Lörrach Neue galenische Zubereitung
US4002718A (en) * 1974-10-16 1977-01-11 Arnar-Stone Laboratories, Inc. Gelatin-encapsulated digoxin solutions and method of preparing the same
US4138565A (en) * 1975-05-31 1979-02-06 Sandoz Ltd. Stable solutions and processes for their preparation
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
GB2022144A (en) * 1978-06-02 1979-12-12 Cabot Corp Molybdenum additives and methods of producing same
DK154607C (da) * 1978-12-21 1989-06-05 Sandoz Ag Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider

Also Published As

Publication number Publication date
ATA242282A (de) 1986-12-15
ZA824513B (en) 1984-02-29
AU561334B2 (en) 1987-05-07
AT383492B (de) 1987-07-10
IT8248677A0 (it) 1982-06-21
FI80591C (sv) 1990-07-10
HK53188A (en) 1988-07-22
KE3814A (en) 1988-08-05
IL66113A0 (en) 1982-09-30
GB2100697B (en) 1985-07-03
FR2508313B1 (fr) 1986-03-21
IE821489L (en) 1982-12-24
FI80591B (fi) 1990-03-30
AU8516282A (en) 1983-01-06
ES8402504A1 (es) 1984-02-01
PT75100A (en) 1982-07-01
US4366145A (en) 1982-12-28
SE8203874D0 (sv) 1982-06-22
CY1430A (en) 1988-09-02
CH655848A5 (de) 1986-05-30
AT377533B (de) 1985-03-25
JPH0255405B2 (sv) 1990-11-27
BE893542A (fr) 1982-12-17
MY8600312A (en) 1986-12-31
JPS584716A (ja) 1983-01-11
CA1191788A (en) 1985-08-13
SE455161B (sv) 1988-06-27
PH22060A (en) 1988-05-20
IE53544B1 (en) 1988-12-07
ATA151282A (de) 1984-08-15
IT1189289B (it) 1988-02-04
DE3222250A1 (de) 1983-01-13
DK280282A (da) 1982-12-25
SG21388G (en) 1988-07-08
NZ201046A (en) 1986-02-21
SE8203874L (sv) 1982-12-25
FI822187A0 (fi) 1982-06-17
ES513359A0 (es) 1984-02-01
GB2100697A (en) 1983-01-06
GR75952B (sv) 1984-08-02
DE3222250C2 (sv) 1992-04-09
FR2508313A1 (fr) 1982-12-31
FI822187L (fi) 1982-12-25
NL8202500A (nl) 1983-01-17
HU190393B (en) 1986-08-28
PT75100B (en) 1985-01-07

Similar Documents

Publication Publication Date Title
GB2124486B (en) Pharmaceutical preparations containing sesquiterpene lactones
DE3172028D1 (en) Pharmaceutical formulation
ZA828797B (en) Pharmaceutical formulation
DE3378523D1 (en) Pharmaceutical formulations
EP0070525A3 (en) Pharmaceutical preparations for external use
DE3367849D1 (en) Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives
GB8315489D0 (en) Stable pharmaceutical tablet
IL66113A (en) Pharmaceutical soft-gelatin capsule formulations containing ergopeptide alkaloids
GB8506656D0 (en) Pharmaceutical capsules
DE3264782D1 (en) Medicinal formulation
DE3269389D1 (en) Pharmaceutical formulations containing antimony
ZA804196B (en) Pharmaceutical formulations
NZ196288A (en) Pharmaceutical active substance administration
IL67336A0 (en) Pharmaceutical composition containing vitamin a
GB2074028B (en) Pharmaceutical formulations
ATA409082A (de) Buegel zum aufhaengen von rasterdeckenelementen
SG62587G (en) Pharmaceutical formulation
ZA822120B (en) Pharmaceutical preparation
JPS57142258A (en) Drug containing tape preparation
JPS5772647A (en) Hard capsule for drug
ZA80753B (en) Pharmaceutical preparation containing benzimidazole 2-derivatives
ZA833692B (en) Pharmaceutical formulations
GB8320429D0 (en) Pharmaceutical preparation
IE791382L (en) Pharmaceutical preparation containing an amantadine¹antiviral compound
IE810190L (en) Pharmaceutical preparation containing¹poly-glycidyl-substituted n-heterocyclics